📅 PUBMED DAILY TRIAGE — 2026-05-25 (Monday)
Window: 2026-05-24T09:00Z → 2026-05-25T09:00Z (CRDT) Topics scanned: 10 | Candidates evaluated: ~51 | Articles reviewed/scored: 17 High priority: 2 | Standard: 15 | Low/archive: 0 | Unsolicited finds: 1 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+ score OR flag: EARLY_CANCER_DETECTION / NOVEL_TREATMENT)
Note: No articles scored ≥8 in watchlist topics. One sentinel article reached 8/10. One watchlist article flagged HIGH via EARLY_CANCER_DETECTION.
Early Cancer Detection (liquid biopsy, ctDNA, cfDNA)
TR-2026-05-25-002 · PMID 42177726 · Practical integration of ctDNA-defined minimal residual disease in gastrointestinal cancers: testing windows and evidence-aligned management frameworks · 6/10 🔴 EARLY_CANCER_DETECTION
Yao N et al., Clin Transl Oncol. Evidence-aligned clinical framework for ctDNA MRD monitoring in GI cancers — directly addresses the translation gap between ctDNA research and daily oncology practice for colorectal/GI settings.
💡 Unsolicited HIGH Find (Sentinel)
TR-2026-05-25-001 · PMID 42178557 · Early population-level impact of Helicobacter pylori eradication on gastric cancer mortality in Japan: a counterfactual analysis of short-term divergence · 8/10 🔴 EARLY_CANCER_DETECTION
Kowada A, Popul Health Metr. Counterfactual modeling study quantifying detectable early mortality divergence from H. pylori eradication programs at the national population level in Japan — potent prevention policy signal for the most effective cancer prevention strategy currently deployed at scale.
🟢⚪ STANDARD (4–7) — Top by Topic
Hematologic Malignancies (AML, MDS, CLL, MPN, Lymphoma)
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-003 | 42178565 | Optical genome mapping uncovers disease-defining variants in adult T-ALL and impacts prognosis | 6/10 | Genomics/Precision Medicine |
| TR-2026-05-25-004 | 42178401 | Clinical features, outcomes, and prognostic factors of lymphocyte-depleted classical Hodgkin lymphoma: SEER analysis | 6/10 | Diagnostics |
| TR-2026-05-25-005 | 42178012 | Trifluoperazine induces ferroptosis in AML by suppressing Nrf2/SLC7A11/GPX4 axis | 5/10 | Drug Development |
| TR-2026-05-25-006 | 42177998 | Role of RNA modifications in multiple myeloma pathogenesis and therapeutic targeting (Review) | 4/10 | Drug Development |
Highest score: 6/10 (TR-003, TR-004). 3 case reports excluded.
CBC-Based Diagnostics + ML in Hematology
Zero results this run — 7th+ consecutive sparse run for this topic. No articles to list.
Early Cancer Detection (liquid biopsy, ctDNA, cfDNA)
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-007 | 42177635 | Tumor-derived EVs in plasma for predicting anti-PD-1 efficacy in NSCLC | 6/10 | Diagnostics |
| TR-2026-05-25-008 | 42177966 | Circulating CHI3L1/YKL-40 in lung cancer: biomarker potential and clinical translation (Review) | 5/10 | Diagnostics |
AI/ML in Clinical Diagnostics and Imaging
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-009 | 42178484 | MRI radiomics + ML for liver fibrosis classification in MAFLD: rat study | 4/10 | Diagnostics |
Only 1 result; animal study capped at 4. 5th+ consecutive run with zero human-validated AI/ML diagnostic papers.
Precision Oncology and Genomic Medicine
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-011 | 42178458 | Neddylation-modified features for prognosis and immune efficacy assessment in HCC | 5/10 | Genomics/Precision Medicine |
(42178565 overlaps with Hematologic malignancies; listed there as primary topic)
Novel Therapeutics (immunotherapy, CAR-T, targeted therapy)
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-010 | 42178511 | ICI association with otologic adverse events: propensity score-matched study | 5/10 | Treatment Innovation |
| TR-2026-05-25-016 | 42178367 | 7th Kidney Cancer Research Summit: Progress in accelerating cures | 4/10 | Treatment Innovation |
High raw volume (31 results); most were preclinical/off-topic. No NOVEL_TREATMENT-flagged articles.
Cardiovascular-Metabolic (GLP-1, SGLT2, cardiometabolic risk)
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-013 | 42177981 | Blood oxygen saturation and associations with autonomic/peripheral neuropathy in diabetes | 6/10 | Diagnostics |
| TR-2026-05-25-012 | 42178112 | IMPACS study design + baseline profile: transforming post-STEMI care | 5/10 | Treatment Innovation |
| TR-2026-05-25-017 | 42178351 | Immune-inflammatory response, nutrition, and metabolic health in MAFLD (Sci Rep) | 5/10 | Public Health |
17 raw results; no direct GLP-1/SGLT2 trial articles in today's window.
Aging, Longevity, and Population Health
| Record | PMID | Title | Score | Category |
|---|---|---|---|---|
| TR-2026-05-25-014 | 42178230 | Dynapenic abdominal obesity and risk of multidimensional multimorbidity: longitudinal cohort evidence | 7/10 | Public Health |
| TR-2026-05-25-015 | 42177830 | Ibadan Chronic Heart Failure Project: baseline profile + 6-month outcomes, n=1,290 (Nigeria) | 7/10 | Public Health 🟡 UNDERSERVED |
Best aging articles today — both at 7/10. humans[MeSH] filter maintained.
Rare Diseases with High Unmet Need
Zero qualifying articles — 2 candidates reviewed, both excluded (1 case report, 1 off-topic primary care paper).
💡 UNSOLICITED FINDS
TR-2026-05-25-001 · PMID 42178557 — already listed as HIGH above.
No additional sentinel articles of note. Other sentinel results (n=9) were off-topic (orthopedics, psychiatry, BMC general medicine) with scores ≤3.
📊 TODAY'S BREAKDOWN
By research category:
- Diagnostics: 4
- Public Health: 4
- Treatment Innovation: 3
- Drug Development: 2
- Genomics/Precision Medicine: 2
- Prevention: 1
- Early Detection: 1
By evidence maturity:
- Exploratory: 9
- Validated: 7
- Potentially Practice-Changing: 0
By watchlist topic (reviewed / kept / highest score):
| Topic | Reviewed | Kept | Highest Score |
|---|---|---|---|
| Hematologic malignancies | 10 | 4 | 6/10 |
| CBC/ML hematology | 0 | 0 | — |
| Early cancer detection (ctDNA/liquid biopsy) | 6 | 3 (1 HIGH) | 6/10 |
| AI/ML clinical diagnostics | 1 | 1 | 4/10 |
| Precision oncology/genomics | 4 | 2 | 6/10 |
| Novel therapeutics (ICI/CAR-T/targeted) | 10 | 2 | 5/10 |
| Cardiovascular-metabolic | 10 | 3 | 6/10 |
| Aging/longevity | 5 | 2 | 7/10 |
| Rare diseases | 2 | 0 | — |
| Sentinel | 10 | 1 (HIGH) | 8/10 |
By source type: peer_reviewed 17 | preprint 0
Topics with zero 8+ articles this run (watchlist): ALL 9 watchlist topics produced 0 HIGH articles. Only sentinel scan produced HIGH.
🔧 RUN NOTES
- Monday run: Moderate indexing volume as expected after weekend (~51 total candidates across all topics).
- CBC/ML hematology: 7th+ consecutive zero-result run. This topic may need broader keyword expansion or temporary deactivation for review.
- AI/ML diagnostics: 5th+ consecutive run with no human-validated clinical AI articles scoring ≥5. Single result today was an animal model study (capped at 4). Query may need broader clinical terms.
- Novel therapeutics: 31 raw results but most off-topic or preclinical. Topic produces volume but low-yield keeps converting. Consider query refinement to filter for clinical-stage findings.
- Rare diseases: 2 candidates reviewed, both excluded. Topic consistently low-yield with current keyword strategy; may benefit from disease-specific expansion.
- Aging/longevity topic: humans[MeSH] filter maintained and effective — 5 clean results, no non-human biology noise.
- Sentinel scan: 168 raw results; only PMID 42178557 (gastric cancer mortality from H. pylori eradication) rose above the noise at 8/10. Notable that no watchlist topic produced a HIGH article today — sentinel scan was the only HIGH source.
- Rolling 7-day note (from state): CBC/ML hematology has produced zero qualifying articles consistently since at least 2026-05-22. AI/ML diagnostics similarly sparse. Both topics warrant query strategy review.